17-44372391-CA-C
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM4PP4_StrongPM2_SupportingPM3_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000419.5(ITGA2B):c.3092del (p.Leu1031ArgfsTer?) variant causes a frameshift and subsequent stop loss. This results in the addition of 90 amino acids to the ITGA2B protein, beyond the cytoplasmic domain (PM4). The variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one patient (Patient GT11 in PMID:25373348) with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, αIIbβ3 surface expression was reduced between 5% and 20% and function was pathological, as measured by flow cytometry (PP4_strong). This patient is compound heterozygous for the maternal c.3092del variant and Leu214Pro (classified Pathogenic by the PD-EP), without confirmation of trans phase (PM3_supporting). In summary this variant meets criteria to be classified as Likely Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_strong, PM2_supporting, PM3_supporting, PM4. (VCEP specifications version 2; date of approval xx/xx/xxxx) LINK:https://erepo.genome.network/evrepo/ui/classification/CA915940323/MONDO:0100326/011
Frequency
Consequence
NM_000419.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- platelet-type bleeding disorder 16Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- Glanzmann thrombastheniaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Glanzmann's thrombastheniaInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- Glanzmann thrombasthenia 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant macrothrombocytopeniaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000419.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ITGA2B | TSL:1 MANE Select | c.3092delT | p.Leu1031ArgfsTer70 | frameshift | Exon 30 of 30 | ENSP00000262407.5 | P08514-1 | ||
| ITGA2B | c.2978delT | p.Leu993ArgfsTer71 | frameshift | Exon 29 of 29 | ENSP00000571366.1 | ||||
| ITGA2B | c.2975delT | p.Leu992ArgfsTer70 | frameshift | Exon 29 of 29 | ENSP00000619736.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461872Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at